# FDA recall D-324-2013

> **Gilead Sciences, Inc.** · Class I · drug recall initiated 2013-01-31.

## Product

Vistide (cidofovir) Injection, 375 mg (75 mg/mL), 5 mL single-use vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA  94404, UPC 3 61958 01011 5; NDC 61958-0101-1.

## Reason for recall

Presence of Particulate Matter: Particulate matter was found in some vials of Vistide (cidofovir injection).

## Distribution

Nationwide in USA, Canada, and UK (Gilead facility in Cork Ireland). Cork facility distributed to Germany/Austria, Italy and Spain.

## Key facts

- **Recall number:** D-324-2013
- **Recalling firm:** Gilead Sciences, Inc.
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-01-31
- **Report date:** 2013-05-22
- **Termination date:** 2014-01-06

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Foster City, CA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-324-2013

## Citation

> AI Analytics. FDA recall D-324-2013. Retrieved 2026-05-26 from https://api.ai-analytics.org/recall/D-324-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*